ベジタリアンカプセルの世界市場

ベジタリアンカプセルの世界市場は2030年までに29億米ドルに到達

2024年に19億米ドルと推定されるベジタリアンカプセルの世界市場は、分析期間2024-2030年にCAGR 7.7%で成長し、2030年には29億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるヒドロキシプロピルメチルセルロースカプセルは、CAGR 9.0%を記録し、分析期間終了時には21億米ドルに達すると予想されます。プルランベジタリアンカプセルセグメントの成長率は、分析期間中CAGR 5.0%と推定されます。

米国市場は5億1,580万米ドルと推定される一方、中国はCAGR 12.2％で成長すると予測される

米国のベジタリアンカプセル市場は、2024年には5億1,580万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを12.2%として、2030年までに6億3,490万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.7%と7.4%と予測されています。欧州では、ドイツがCAGR 5.1%で成長すると予測されています。

世界のベジタリアンカプセル市場- 主要動向と促進要因のまとめ

なぜベジタリアンカプセルはヘルス＆ウェルネス分野で好まれるのか？

ベジタリアンカプセルは、従来のゼラチンカプセルに代わる植物由来のカプセルで、主にヒドロキシプロピルメチルセルロース（HPMC）や発酵プルランなどのセルロース系ポリマーから作られています。これらのカプセルは、ベジタリアン、ビーガン、コーシャ、ハラルなどの消費者の倫理的、文化的、食事的嗜好に適合する非動物性のデリバリー・フォーマットを提供します。味はニュートラルで、アレルゲンを含まず、幅広い有効成分との適合性があるため、栄養補助食品、機能性食品、植物由来の製剤に適しています。倫理的な調達と成分の透明性が主流になるにつれ、ベジタリアンカプセルは製品開発者に、消費者に優しい表示のためのコンプライアンスソリューションを提供します。

ゼラチンカプセルとは異なり、ベジタリアンカプセルは動物由来のコラーゲンに依存しないため、BSEやTSE感染の心配がありません。この違いは、原材料の由来や交差汚染のリスクが吟味される健康志向の市場では特に重要です。熱に弱く、湿気に敏感な内容物への適性は、クリーンラベルの栄養補助食品における役割をさらに強化します。製薬会社は、包括的な製品設計に対する需要の高まりを受けて、市販薬用の植物由来カプセルを検討するケースが増えています。

規制・製造動向は製品の標準化をどのように支えているか？

規制コンプライアンスと第三者認証は、世界市場でベジタリアンカプセルを販売する上で不可欠となっています。製剤メーカーは、輸出要件や表示要件を満たすため、ビーガン、ハラル、コーシャの各認証機関から認証を受けたカプセルを求めるようになっています。この規制上の保証は、厳格な食事法や宗教的基準がある市場では特に重要です。水分含有量、保存可能期間、酸素透過性に関する品質基準も、従来のゼラチンカプセルの性能に合わせて改良されています。

メーカーは、カプセル化のスピードや精度に妥協することなく、植物由来のフィルムを扱える自動カプセル製造技術に投資しています。このようなアップグレードにより、コスト効率の高いスケールアップが可能になり、治療分野全体への応用が広がっています。加えて、賦形剤調達とトレーサビリティにおける透明性は、非遺伝子組み換え、グルテンフリー、アレルゲンフリーの成分表示に対する嗜好の高まりに対応するカプセルサプライヤーに役立っています。ベジタリアンカプセルはこのような規制や運用の改善により、有効性と信頼性の両面でゼラチンベースのシステムと肩を並べるようになってきています。

ベジタリアンカプセルシステムの多様性を高める技術革新とは？

製品イノベーションは、ベジタリアンカプセルの機能範囲を拡大し、遅延放出、腸溶コーティング、徐放性剤形をサポートすることに重点を置いています。メーカーは胃酸に耐え、消化管内で崩壊し、特定の栄養素や活性化合物のバイオアベイラビリティを向上させるカプセルを開発しています。耐酸性で湿気密封性のカプセル殻は、小腸に到達するまで保護が必要なプロバイオティクスや酵素製剤にとって特に価値があります。

二重充填カプセルや透明コーティングカプセルなどの組み合わせ剤形も、視覚的アピールや性能の差別化を高めるために導入されています。油性、粉末、顆粒充填用に調整されたカプセルは、サプリメントブランドがベジタリアンの主張を守りながら製品を多様化することを可能にしています。サイズ、色、ブランド名のカスタマイズは、栄養補助食品会社がパッケージの美観をブランド・アイデンティティと一致させるのに役立っています。これらの機能は、棚で存在感を示し、プレミアムなポジショニングを強化しようとする消費者直販のサプリメントブランドにとって特に重要です。

どのような市場セグメンテーションがセグメントや地域全体の需要を牽引しているか？

ベジタリアンカプセル市場の成長は、消費者の食事パターン、認証要件、製品イノベーションに関連するいくつかの要因によって牽引されています。北米、欧州、東南アジアでは、植物由来のサプリメントやクリーンラベル製剤に対する需要の高まりが、ゼラチンから植物由来のカプセルへの移行を後押ししています。製薬会社はまた、文化的または倫理的な制約がある患者層を取り込むためのベジタリアンカプセルを模索しています。プロバイオティクス、ハーブ、機能性サプリメントカテゴリーの成長は、耐酸性と耐湿性を備えたベジタリアンカプセルフォーマットの需要を強化しています。カプセル殻材料の進歩は、製造機械の改良と相まって、スケールアップの実現可能性とコスト効率を向上させています。さらに、より明確な表示を求める規制の後押しと、トレーサビリティのある動物性不使用の原材料に対する消費者の関心が、受託製造業者とサプリメント・ブランドの双方にベジタリアン・カプセルの採用を優先させるよう迫っています。個別化された栄養の拡大と併用投与製品への需要は、治療と健康の用途におけるベジタリアンカプセルの市場ポジションをさらに強化しています。

セグメント

製品（ヒドロキシプロピルメチルセルロースカプセル、プルランベジタリアンカプセル）、機能性（即時放出機能性、持続放出機能性、遅延放出機能性）、用途（抗生物質・抗菌剤用途、ビタミン・栄養補助食品用途、抗炎症剤用途、心血管治療用途、制酸剤・消炎剤用途）、最終用途（医薬品最終用途、栄養補助食品最終用途、受託製造機関最終用途、化粧品最終用途）

調査対象企業の例

• ACG（Associated Capsules Pvt Ltd）
• Aenova Group
• AlfaCaps LLC
• Ashland Inc.
• Bright Pharma Caps
• CapsCanada
• Capsugel（Lonza Group）
• Captek Softgel International Inc.
• Catalent Inc.
• Dow Chemical
• Erkang
• EuroCaps
• Lotte Fine Chemical
• Nouryon
• QUALICAPS（Roquette Freres）
• Robinson Pharma Inc.
• Roquette Freres
• Shandong Healsee Capsule Ltd.
• Shin-Etsu Chemical Co., Ltd.
• Sirio Europe GmbH

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Vegetarian Capsules Market to Reach US$2.9 Billion by 2030

The global market for Vegetarian Capsules estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Hydroxypropyl Methyl Cellulose Capsules, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Pullulan Vegetarian Capsules segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$515.8 Million While China is Forecast to Grow at 12.2% CAGR

The Vegetarian Capsules market in the U.S. is estimated at US$515.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$634.9 Million by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Vegetarian Capsules Market - Key Trends & Drivers Summarized

Why Are Vegetarian Capsules Preferred Across Health and Wellness Segments?

Vegetarian capsules are plant-derived alternatives to traditional gelatin capsules and are made primarily from cellulose-based polymers such as hydroxypropyl methylcellulose (HPMC) or fermented pullulan. These capsules provide a non-animal delivery format that meets the ethical, cultural, and dietary preferences of vegetarian, vegan, kosher, and halal consumers. Their neutral taste, absence of allergens, and compatibility with a wide range of active ingredients make them suitable for dietary supplements, functional foods, and botanical-based formulations. As ethical sourcing and ingredient transparency become mainstream, vegetarian capsules offer product developers a compliant solution for consumer-friendly labeling.

Unlike gelatin capsules, vegetarian options do not rely on animal-derived collagen and are thus free from BSE and TSE transmission concerns. This distinction is particularly important in health-conscious markets where ingredient origin and cross-contamination risks are scrutinized. Their suitability for heat-sensitive and moisture-sensitive contents further strengthens their role in clean-label nutraceuticals. Increasingly, pharmaceutical companies are exploring plant-based capsules for over-the-counter medications in response to growing demand for inclusive product design.

How Are Regulatory and Manufacturing Trends Supporting Product Standardization?

Regulatory compliance and third-party certifications have become essential in marketing vegetarian capsules across global markets. Formulators increasingly seek capsules certified by recognized vegan, halal, and kosher authorities to meet export and labeling requirements. This regulatory assurance is especially significant in markets with strict dietary laws or religious standards. Quality standards related to moisture content, shelf life, and oxygen permeability are also being refined to match the performance of traditional gelatin capsules.

Manufacturers are investing in automated capsule production technologies capable of handling plant-based films without compromising on encapsulation speed or accuracy. These upgrades are enabling cost-efficient scale-up and broader application across therapeutic segments. In addition, transparency in excipient sourcing and traceability are helping capsule suppliers address the growing preference for non-GMO, gluten-free, and allergen-free ingredient declarations. These regulatory and operational improvements are helping vegetarian capsules gain parity with gelatin-based systems in both efficacy and reliability.

What Innovations Are Enhancing the Versatility of Vegetarian Capsule Systems?

Product innovation is focused on expanding the functional scope of vegetarian capsules to support delayed-release, enteric-coated, and sustained-release dosage forms. Manufacturers are developing capsules that can withstand stomach acid and disintegrate in targeted sections of the digestive tract, improving the bioavailability of specific nutrients or active compounds. Acid-resistant and moisture-sealed capsule shells are particularly valuable for probiotic and enzyme formulations that require protection until they reach the small intestine.

Combination dosage forms, including dual-fill capsules and transparent-coated variants, are also being introduced to enhance visual appeal and performance differentiation. Capsules tailored for oil-based, powder, and granular fills are allowing supplement brands to diversify product offerings while adhering to vegetarian claims. Customization in size, color, and branding is helping nutraceutical companies align packaging aesthetics with brand identity. These capabilities are particularly important for direct-to-consumer supplement brands seeking to create shelf presence and reinforce premium positioning.

What Market-Specific Factors Are Driving Demand Across Segments and Regions?

Growth in the vegetarian capsules market is driven by several factors linked to consumer dietary patterns, certification requirements, and product innovation. Increasing demand for plant-based supplements and clean-label formulations across North America, Europe, and Southeast Asia is supporting the shift from gelatin to plant-derived capsules. Pharmaceutical companies are also exploring vegetarian capsules for inclusivity in patient demographics with cultural or ethical restrictions. Growth of probiotic, herbal, and functional supplement categories is reinforcing demand for acid-resistant and moisture-tolerant vegetarian capsule formats. Advancements in capsule shell materials, coupled with enhancements in production machinery, are improving scale-up feasibility and cost-efficiency. Additionally, regulatory push for clearer labeling and consumer interest in traceable, animal-free ingredients are compelling both contract manufacturers and supplement brands to prioritize vegetarian capsule adoption. Expansion of personalized nutrition and demand for combination-dose products is further strengthening the market position of vegetarian capsules across therapeutic and wellness applications.

SCOPE OF STUDY:

The report analyzes the Vegetarian Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Hydroxypropyl Methyl Cellulose Capsules, Pullulan Vegetarian Capsules); Functionality (Immediate-Release Functionality, Sustained-Release Functionality, Delayed-Release Functionality); Application (Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application, Cardiovascular Therapy Application, Antacid & Antiaffluent Application); End-Use (Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use, Cosmetics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• ACG (Associated Capsules Pvt Ltd)
• Aenova Group
• AlfaCaps LLC
• Ashland Inc.
• Bright Pharma Caps
• CapsCanada
• Capsugel (Lonza Group)
• Captek Softgel International Inc.
• Catalent Inc.
• Dow Chemical
• Erkang
• EuroCaps
• Lotte Fine Chemical
• Nouryon
• QUALICAPS (Roquette Freres)
• Robinson Pharma Inc.
• Roquette Freres
• Shandong Healsee Capsule Ltd.
• Shin-Etsu Chemical Co., Ltd.
• Sirio Europe GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Vegetarian Capsules - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Shift Toward Plant-Based and Ethical Supplement Formats Propels Long-Term Adoption of Vegetarian Capsules
  • Growing Demand for Animal-Free, Gelatin-Free Dosage Forms Drives Market Expansion Across Nutraceutical Applications
  • Increasing Consumer Awareness of Dietary Restrictions Strengthens Demand for Halal, Kosher, and Allergen-Free Capsules
  • Rapid Expansion of Vegan, Ayurvedic, and Herbal Supplement Markets Generates Opportunities for Vegetarian Capsule Manufacturers
  • Rising Scrutiny of Animal-Derived Ingredients and BSE-Related Concerns Accelerate Transition to Vegetarian Capsule Formats
  • Technological Advancements in HPMC and Pullulan Capsule Production Support Heat Stability and Fill Versatility
  • Preference for Clean-Label and Transparent Supplement Solutions Sustains Innovation in Additive-Free Capsule Shells
  • Surge in Preventive Healthcare and Wellness Routines Expands the Addressable Market for Daily Use Vegetarian Capsules
  • Aging Population Need for Gut-Friendly and Digestible Dosage Forms Reinforces Demand for Plant-Based Capsules
  • Expanding E-Commerce and DTC Nutraceutical Channels Increase Visibility and Sales of Certified Vegetarian Capsules
  • High Growth in Sports Nutrition, Cognitive Health, and Immune Support Segments Creates Cross-Sector Demand for Veg Capsules
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Vegetarian Capsules Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pullulan Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pullulan Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pullulan Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Antacid & Antiaffluent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Antacid & Antiaffluent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Antacid & Antiaffluent Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Antibiotic & Antibacterial Drugs Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Antibiotic & Antibacterial Drugs Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Vitamin & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Vitamin & Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anti-Inflammatory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Anti-Inflammatory Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiovascular Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Nutraceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Nutraceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Nutraceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Contract Manufacturing Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cosmetics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Immediate-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Sustained-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Sustained-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Sustained-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Delayed-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Delayed-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Delayed-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• JAPAN
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• CHINA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• EUROPE
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Vegetarian Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• FRANCE
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• GERMANY
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Vegetarian Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• INDIA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Vegetarian Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Vegetarian Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030
• AFRICA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Vegetarian Capsules by Product - Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Vegetarian Capsules by Product - Percentage Breakdown of Value Sales for Hydroxypropyl Methyl Cellulose Capsules and Pullulan Vegetarian Capsules for the Years 2014, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Vegetarian Capsules by Application - Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Vegetarian Capsules by Application - Percentage Breakdown of Value Sales for Antacid & Antiaffluent Application, Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application and Cardiovascular Therapy Application for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Vegetarian Capsules by End-Use - Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Vegetarian Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use and Cosmetics End-Use for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Vegetarian Capsules by Functionality - Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Vegetarian Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained-Release Functionality and Delayed-Release Functionality for the Years 2014, 2025 & 2030

IV. COMPETITION